Müge Aydın Tufan

Müge Aydın Tufan

Auto-generated profile, based on publicly available information

Müge Aydın Tufan

Başkent Üniversitesi Adana Uygulama ve Araştırma Merkezi

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2019 in European Journal of Rheumatology
Verified
Journal Article
Open access
GCGozde Yildirim Cetin
Gozde Yildirim Cetin
ISIsmail Sari
Ismail Sari
TKTimuçin Kaşifoğlu
Timuçin Kaşifoğlu
MÇMuhammed Çınar
Muhammed Çınar
MSMehmet Sayarlıoğlu
Mehmet Sayarlıoğlu
DSDilek Solmaz
Dilek Solmaz
Objective: Familial Mediterranean fever (FMF) is the most common autoinflammatory disease. Most of the identified disease-causing mutations are located on exon 10. As the number of studies about the effect of the exonal location of the mutation and its phenotypic expression is limited, we aimed to investigate whether the exonic location of the Mediterranean fever (MEFV) mutation has an effect on the clinical manifestation in patients with FMF. Methods: Study population was derived from the main FMF registry that included 2246 patients from 15 different rheumatology clinics. We categorized the mutations according to their exon locations and retrieved the clinical and demographic information from the database. Results: Patients having the MEFV mutations on exon 2 or 10 (n:1526) were divided into three subgroups according to the location of the MEFV mutations: Group 1 (exon 2 mutations), Group 2 (exon 10 mutations), and Group 3 (both exon 2 and exon 10 mutations). Group 2 patients were of a significantly younger age at onset, and erysipel-like erythema, arthritis, amyloidosis, and a family history of FMF were more common in this group. Conclusion: Patients with FMF and exon 10 mutations show more severe clinical symptoms and outcome. Exon 2 mutations tend to have a better outcome. Cite this article as: Yaşar Bilge Ş, Solmaz D, Şenel S, Emmungil H, Kılıç L, Yılmaz Öner S, et al. Exon 2: Is it the good police in familial mediterranean fever? Eur J Rheumatol 2019; 6(1): 33-6.

30 September 2021 in Archives of Rheumatology
Verified
Journal Article
Open access
PDF file
MTMüge Aydın Tufan
Müge Aydın Tufan
NTNihan Tekkarışmaz
Nihan Tekkarışmaz
Objectives: The aim of this study was to identify predictors of mortality in granulomatosis with polyangiitis (GPA) patients and to seek the ways of improving survival in GPA patients. Patients and methods: Between January 2005 and June 2020, a total of 60 patients (26 males, 34 females; median age: 49 years; range, 19 to 75 years) who were diagnosed with GPA were retrospectively analyzed. Demographic, clinical, laboratory, and radiological findings of all patients were recorded. Survival rates were analyzed using the Kaplan-Meier plot. Results: The median follow-up was 36 months, and 10 (16.7%) patients died during the study period. Univariate analysis showed that the prognostic values were attributed to high serum creatinine levels (>2.1 mg/dL; p=0.01), proteinuria (p=0.01), dialysis-requiring renal damage at the time of diagnosis (p=0.01) or at any time during follow-up (p=0.01), low lymphocyte levels (p=0.01), hypoalbuminemia (p=0.04), absence of upper respiratory tract involvement (p=0.01), presence of lung involvement with cavitary lesions (p=0.01), high Birmingham Vascular Activity Score (p=0.02), and history of serious infection (p=0.01). In the multivariate analysis, the presence of renal damage requiring dialysis at any time during follow-up (relative risk [95% confidence interval]: 21 [4.1-18.3]; p=0.01) was found to be an independent predictor of mortality. Immunosuppressive drugs exerted no effect on mortality, and the most common causes of death were infections (50%). Conclusion: The presence of dialysis-requiring renal damage is the most important risk factor for mortality in GPA patients. These patients should be followed more closely and carefully to improve survival.

30 August 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
MTMüge Aydin Tufan
Müge Aydin Tufan
NTNihan Tekkarişmaz
Nihan Tekkarişmaz
AYAhmet Eftal Yücel
Ahmet Eftal Yücel
Background This study aimed to determine the frequency of relapse, the risk factors for relapse, and the correlation of relapse with immunosuppressive regimens in patients with granulomatosis polyangiitis (GPA). Method The demographic characteristics, the clinical, laboratory, and radiological findings, the immunosuppressive treatment regimens, and the remission and relapse rates of 50 patients with GPA were obtained retrospectively from medical records. Results The mean relapse-free survival rates at years1, 3, and 5 were 82%, 60%, and 50%, respectively. Increased relapse rates were observed in patients who had cavitary lung lesions (52.2% vs. 22.2%, p=0.04) and in those who had elevated serum creatinine levels (1.8 vs. 0.9, p=0.00). The patients received two different types of remission induction therapies;36% of them received the combination therapy involving cyclophosphamide (CYC) and rituximab (RTX) and 62% received CYC alone. Relapse was observed in 22.3% of the patients who received the combination remission induction therapy and in 61.3% of the patients who received CYC alone (p=0.003). Conclusion An increased risk of relapse was observed in patients who had cavitary lung lesions and in those who had elevated serum creatinine levels. The combined use of RTX and CYC for the remission therapy in GPA reduced the relapse rates compared with the use of CYC alone.

7 January 2020 in European Journal of Rheumatology
Verified
Journal Article
Open access
MÇMuhammet Çınar
Muhammet Çınar
NONoura Al Osaimi
Noura Al Osaimi
UKUmut Klayoncu
Umut Klayoncu
SBSibel Bakirci
Sibel Bakirci
LKLevent Kilic
Levent Kilic
GKGezmiş Kimyon
Gezmiş Kimyon
Objective: Our aim is to test the validity of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome, to assess the psoriasis severity within the scope of rheumatology. Methods: Within the PsA international database (PSART-ID), 571 patients had PSI, while 322 of these also showed body surface area (BSA). Correlations between PSI, BSA, and other patient- and physician-reported outcomes were investigated. Results: There was a good correlation between PSI and BSA (r=0.546, p<0.001), which was even higher for mild psoriasis (BSA<3 (n=164): r=0.608, p<0.001). PSI significantly correlated with fatigue, pain, and patient and physician global parameters (p<0.001). Conclusion: PSI has a good correlation with other patient- and physician-reported outcomes, and our findings support its use in rheumatology practice. Cite this article as: Aydın SZ, Kimyon G, Özişler C, Tarhan FG, Kasapoğlu Günal E, Küçük A, et al. Psoriasis Symptom Inventory (PSI) as a patient-reported outcome in mild psoriasis: Real life data from a large psoriatic arthritis registry. Eur J Rheumatol 2020; 7(2): 64-7.

26 December 2022 in Journal of Medicine and Palliative Care
Verified
Journal Article
Open access
PDF file
MTMüge Aydin Tufan
Müge Aydin Tufan
DKDerya Kaşkari̇
Derya Kaşkari̇
Amaç: Bu çalışmada immünglobülin G4 ilişkili hastalıkta (IgG4-İH) klinik tutulum özelliklerinin, nüks oranlarının ve nüks ile ilişkili faktörlerin belirlenmesi amaçlanmıştır. Gereç ve Yöntem: Çalışmamıza IgG4-İH tanısıyla 36 hasta dahil edildi. Bu hastaların demografik, klinik, laboratuvar, radyolojik bulguları, steroid, immünsüpresif tedavi rejimleri ve nüks oranları retrospektif olarak kaydedildi. Bulgular: Hastaların %36’sı kadındı ve ortalama yaş 58,5±13,2 yıldı. Remisyon oranı %56, nüks oranı ise %19 olarak tespit edildi. İlk tanı anında pankreatit ve retroperitoneal fibrozisi olan hastalarda nüks oranı daha yüksekti (p=0.001). Tek değişkenli analize göre, nüks ile ilişkili bulunan faktörler şu şekildeydi: Hastalık süresi (p=0.001), alerji öyküsü (p=0.018), sigara kullanımı (p=0.027), eozinofili (p=0.001), total IgE (p=0.005) ve kreatinin yüksekliği (p=0.001). Çok değişkenli analizde ise hastalık süresi (Odds oranı (OO) [%95 güven aralığı (GA)]=1.1. [1.01-1.20]; p=0.016) nüks ile ilişkili bağımsız risk faktörü olarak bulundu. Sonuç: IgG4-İH’li hastalıkta nüks riski, tanı anında pankreas ve retroperitoneal tutulumu olması, alerji öyküsü, sigara kullanımı, eozinofili, total IgE ve kreatinin yüksekliği ile ilişkiliydi. Bu risk faktörlerini taşıyan hastalarda kombine immünsüpresif tedavilerin tercihi ve steroid dozunun kontrollü azaltılması nüksü engellemekte yararlı olabilir.

22 October 2010
Verified
Journal Article
Closed access
MTMuge Aydin Tufan
Muge Aydin Tufan
KHKart-Koseoglu Hamide
Kart-Koseoglu Hamide
EDErsozlu-Bozkirli Duygu
Ersozlu-Bozkirli Duygu
AOAzap Ozlem
Azap Ozlem
TKTufan Kadir
Tufan Kadir
YEYucel Ahmet Eftal
Yucel Ahmet Eftal